Phase-out mechanism for telemonitoring activities reimbursed via LATM introduced in France

On May 20, 2026, the French Ministry of Health, Family, Autonomy and People with Disabilities published a decree in the Official Journal introducing a phase-out mechanism for certain medical telemonitoring activities reimbursed under the List of Medical Telemonitoring Activities (LATM).

The decree applies when a newly registered telemonitoring activity demonstrates an improvement in medical benefit compared with an activity already listed for the same indication. In such cases, the existing activity will remain reimbursed for a transitional period of 36 months following the registration of the superior activity. During this transition period, the tariff for the previously registered activity will be reduced annually by 10% relative to the tariff of the newly registered activity. 

The Decree entered into force on the day following its publication.

This measure introduces a structured “managed exit” pathway for older reimbursed telemonitoring activities in France. It signals that LATM listing is not static: once a superior solution is registered for the same indication, older activities may face progressive tariff reductions and eventual delisting.

For manufacturers, the decree increases the importance of demonstrating and maintaining comparative clinical value. For innovators, it creates a clearer pathway for superior solutions to replace legacy technologies, while giving providers a three-year transition period to adapt.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.